(Q35790348)

10 August 2017

1 reference

title

Therapeutic potential of oral tolerance (English)

1 reference

10 August 2017

Lloyd Mayer

1

1 reference

PubMed ID

15173830

10 August 2017

Ling Shao

series ordinal

2

1 reference

10 August 2017

1 June 2004

1 reference

Nature Reviews Immunology

10 August 2017

1 reference

10 August 2017

4

1 reference

10 August 2017

6

1 reference

10 August 2017

407-419

1 reference

Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy

10 August 2017

1 reference

Anatomical basis of tolerance and immunity to intestinal antigens

21 January 2018

1 reference

Role of Toll-like receptors in pathogen recognition.

21 January 2018

1 reference

NODs: intracellular proteins involved in inflammation and apoptosis

21 January 2018

1 reference

Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells

21 January 2018

1 reference

CD8 T-cells are not essential for the induction of "low-dose" oral tolerance.

21 January 2018

1 reference

A novel strategy for organ allografts using sublethal (7 Gy) irradiation followed by injection of donor bone marrow cells via portal vein.

21 January 2018

1 reference

Visualization of peptide presentation following oral application of antigen in normal and Peyer's patches-deficient mice.

21 January 2018

1 reference

Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

21 January 2018

1 reference

Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node

21 January 2018

1 reference

A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes

21 January 2018

1 reference

Peripheral deletion of antigen-reactive T cells in oral tolerance.

21 January 2018

1 reference

T cell anergy and costimulation

21 January 2018

1 reference

Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen

21 January 2018

1 reference

Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation.

21 January 2018

1 reference

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

21 January 2018

1 reference

An essential role for Scurfin in CD4+CD25+ T regulatory cells

21 January 2018

1 reference

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

21 January 2018

1 reference

TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice

21 January 2018

1 reference

Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia

21 January 2018

1 reference

Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

CTLA-4 is required for the induction of high dose oral tolerance.

21 January 2018

1 reference

Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells

21 January 2018

1 reference

Immunogenicity of recombinant type IX collagen in murine collagen-induced arthritis

21 January 2018

1 reference

Induction of specific transplantation immunity by oral immunization with allogeneic cells.

21 January 2018

1 reference

Allochimeric class I MHC protein-induced tolerance by partial TCR engagement requires activation of both CTL4- and common gamma-chain-dependent cytokine signals.

21 January 2018

1 reference

Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking

21 January 2018

1 reference

Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1.

21 January 2018

1 reference

Allelic variation of MHC structure alters peptide ligands to induce atypical partial agonistic CD8+ T cell function

21 January 2018

1 reference

A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes

21 January 2018

1 reference

The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes.

21 January 2018

1 reference

Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation

21 January 2018

1 reference

The beta 2-adrenergic agonist salbutamol potentiates oral induction of tolerance, suppressing adjuvant arthritis and antigen-specific immunity

21 January 2018

1 reference

A blood-borne antigen induces rapid T-B cell contact: a potential mechanism for tolerance induction

21 January 2018

1 reference

Systemic antigen in the treatment of T-cell-mediated autoimmune diseases

21 January 2018

1 reference

Nasal instillation of gpMBP can exacerbate murine EAE: effect of mucosal priming is an age-dependent phenomenon

21 January 2018

1 reference

Suppression of asthma-like responses in different mouse strains by oral tolerance.

21 January 2018

1 reference

Future therapeutic options in food allergy.

21 January 2018

1 reference

Oral desensitizing treatment in food allergy: clinical and immunological results

21 January 2018

1 reference

Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen--first results.

21 January 2018

1 reference

Control of rheumatoid arthritis by oral tolerance

21 January 2018

1 reference

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

21 January 2018

1 reference

United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center

21 January 2018

1 reference

Treatment of Uveitis by Oral Administration of Retinal Antigens: Results of a Phase I/II Randomized Masked Trial

21 January 2018

1 reference

Induction of Autoimmune Diabetes by Oral Administration of Autoantigen

21 January 2018

1 reference

Inhibition of experimental drug allergy by prior feeding of the sensitizing agent

21 January 2018

1 reference

Therapeutic manipulation of the immune system: enhancement of innate and adaptive mucosal immunity

31 March 2020

1 reference

Respiratory Tolerance in the Protection Against Asthma

31 March 2020

1 reference

Local control of the immune response in the liver

31 March 2020

1 reference

Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells

31 March 2020

1 reference

Effect of in vivo depletion of CD4+ and CD8+ cells on the induction and maintenance of oral tolerance

31 March 2020

1 reference

CD4+ but not CD8+ T cells are required for the induction of oral tolerance

31 March 2020

1 reference

The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding

31 March 2020

1 reference

Successful allogeneic bone marrow transplantation (BMT) by injection of bone marrow cells via portal vein: stromal cells as BMT-facilitating cells

31 March 2020

1 reference

Modulation of immune responses after portal venous injection of antigen

31 March 2020

1 reference

Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model

31 March 2020

1 reference

Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice

31 March 2020

1 reference

Selective emigration of suppressor T cells from Peyer's patches

31 March 2020

1 reference

Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches

31 March 2020

1 reference

Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches.

31 March 2020

1 reference

Splenectomy abrogates the induction of oral tolerance in experimental autoimmune uveoretinitis

31 March 2020

1 reference

Requirement for splenic CD4+ T cells in the immune privilege of the anterior chamber of the eye

31 March 2020

1 reference

Induction of anterior chamber-associated immune deviation requires an intact, functional spleen

31 March 2020

1 reference

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

31 March 2020

1 reference

The oral administration of low-dose antigen induces activation followed by tolerization, while high-dose antigen induces tolerance without activation

31 March 2020

1 reference

Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-beta/interleukin-10 and suppression of experimental autoimmune encephalomyelitis

31 March 2020

1 reference

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

31 March 2020

1 reference

Murine model of oral tolerance. Induction of Fas-mediated apoptosis by blockade of interleukin-12

31 March 2020

1 reference

Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration

31 March 2020

1 reference

Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells

31 March 2020

1 reference

Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients

31 March 2020

1 reference

IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis

31 March 2020

1 reference

A Comparative Study between T Regulatory Type 1 and CD4+CD25+ T Cells in the Control of Inflammation

31 March 2020

1 reference

Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide

31 March 2020

1 reference

Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells

31 March 2020

1 reference

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen

31 March 2020

1 reference

Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions

31 March 2020

1 reference

Abrogation of oral tolerance by feeding encapsulated antigen

31 March 2020

1 reference

Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice

31 March 2020

1 reference

Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse

31 March 2020

1 reference

Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide

31 March 2020

1 reference

Differences between two strains of myelin basic protein (MBP) TCR transgenic mice: implications for tolerance induction

31 March 2020

1 reference

Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis

31 March 2020

1 reference

Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides

31 March 2020

1 reference

Oral feeding of an immunodominant MHC donor-derived synthetic class I peptide prolongs graft survival of heterotopic cardiac allografts in a high-responder rat strain combination

31 March 2020

1 reference

The effect of oral immunization on corneal allograft survival

31 March 2020

1 reference

Induction of donor-specific hyporesponsiveness and prolongation of cardiac allograft survival by jejunal administration of donor splenocytes

31 March 2020

1 reference

Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice

31 March 2020

1 reference

Phenotypic analysis of oral tolerance to alloantigens: evidence that the indirect pathway of antigen presentation is involved

31 March 2020

1 reference

A role for persisting antigen, antigen presentation, and ICAM-1 in increased renal graft survival after oral or portal vein donor-specific immunization

31 March 2020

1 reference

Oral immunisation as a strategy for enhancing corneal allograft survival

31 March 2020

1 reference

CD4+CD25+ T-cell development is regulated by at least 2 distinct mechanisms

31 March 2020

1 reference

Induction of tolerance by oral administration of a tolerogenic allochimeric donor/recipient class I MHC protein.

31 March 2020

1 reference

Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines

31 March 2020

1 reference

Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit

31 March 2020

1 reference

Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells

31 March 2020

1 reference

Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes

31 March 2020

1 reference

Oral tolerance induction in dermatophagoides pteronyssinus-sensitized mice induces inhibition of IgE response and upregulation of TGF-beta secretion

31 March 2020

1 reference

Active suppression in orally tolerized rats coincides with in situ transforming growth factor-beta (TGF-beta) expression in the draining lymph nodes

31 March 2020

1 reference

Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis.

31 March 2020

1 reference

Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells

31 March 2020

1 reference

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance

31 March 2020

1 reference

Immune Responses to Fed Protein Antigens in Mice. 3. Systemic Tolerance or Priming Is Related to Age at Which Antigen Is First Encountered

31 March 2020

1 reference

Modulation of intestinal and systemic immune responses to a fed protein antigen, in mice

31 March 2020

1 reference

Decrease in systemic tolerance to fed ovalbumin in indomethacin-treated mice

31 March 2020

1 reference

Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen.

31 March 2020

1 reference

Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse

31 March 2020

1 reference

Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals

31 March 2020

1 reference

Gender differences in protection from EAE induced by oral tolerance with a peptide analogue of MBP-Ac1-11

31 March 2020

1 reference

Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis

31 March 2020

1 reference

Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease

31 March 2020

1 reference

Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis

31 March 2020

1 reference

The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis

31 March 2020

1 reference

Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen

31 March 2020

1 reference

Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial

31 March 2020

1 reference

Treatment of rheumatoid arthritis by oral administration of bovine tracheal type II collagen

31 March 2020

1 reference

Effects of oral administration of type II collagen on rheumatoid arthritis

31 March 2020

1 reference

Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRI1370

1 reference

10 August 2017

1 reference

PubMed ID

15173830